You are here

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: March 2022 to August 2025

AbstractFullPdf
Mar 2022442458227
Apr 2022242249115
May 202218418872
Jun 202216216548
Jul 202213213544
Aug 202220520657
Sep 202215716253
Oct 202217217656
Nov 202215215256
Dec 202213113351
Jan 2023808024
Feb 2023808241
Mar 2023545445
Apr 2023535532
May 2023525329
Jun 2023474717
Jul 2023454529
Aug 2023525227
Sep 2023393927
Oct 2023424219
Nov 2023686827
Dec 2023676849
Jan 2024737356
Feb 2024595943
Mar 2024555578
Apr 2024676861
May 2024535328
Jun 2024747843
Jul 2024646435
Aug 2024514831
Sep 2024606036
Oct 2024474736
Nov 2024505130
Dec 2024838564
Jan 2025595931
Feb 202515415562
Mar 2025707056
Apr 2025808250
May 2025596060
Jun 2025414125
Jul 2025210
Aug 2025110
Total386039191970